UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
 
NEW YORK HEALTH CARE, INC.

(Exact Name of Registrant as Specified in Its Charter)

New York
 
1-12451
 
11-2636089
(State or Other Jurisdiction
 
(Commission
 
(IRS Employer
of Incorporation
 
File Number)
 
Identification No.)

            
1850 McDonald Avenue, Brooklyn, New York
11223
 
                    
(Address of Principal Executive Offices)
(Zip Code)
 
(212) 679-7778  

  (Registrant's Telephone Number, Including Area Code)
 

  (Former Name or Former Address, if Changed Since Last Report) 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

INFORMATION TO BE INCLUDED IN THE REPORT

Section 8 - Other Events

Item 8.01 Other Events

New York Health Care, Inc. (the “Company ) has filed a Form 15 today with the Securities and Exchange Commission ( SEC ) to voluntarily deregister its common stock. The Company is eligible to deregister because it has fewer than 300 holders of record of its common stock. In filing the Fo rm 15, the Company's obligations to file certain reports and forms with the SEC, including Forms 10-K, 10-Q and 8-K, are immediately suspended. The Company expects that deregistration of its common stock will become effective within 90 days.
 
The Company is deregistering because it believes that the incremental cost of compliance with the Sarbanes-Oxley Act of 2002 and other public company reporting requirements does not provide a discernable benefit to the Company and is not in the best interest s of its shareholders. Factors influencing the Company's decision include the following :
 
– The high accounting, legal and administrative costs of preparing and filing periodic reports and other filings with the SEC in comparison to the size of the Company.
– The need for senior management of the Company to devote more time to the business of the Company .
– The need to maintain the confidentiality of sensitive business information that would otherwise require SEC disclosure.
– The already limited trading in the Company's common stock. .
–  The fact that current trading prices of the common stock make it unlikely that the Company could e ffectively use its common stock to compensate employees, raise capital or make acquisitions.

As a result of deregistering with the SEC, the Company's common stock will cease to be eligible to trade on the Over-the-Counter Bulletin Board. The Company's securities will continue to be traded over the counter on the Pink Sheets, but the Company can make no assurance that any broker will continue to make a market in the Company's common stock.
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
NEW YORK HEALTH CARE, INC.
 
(Registrant)
     
Date: January 7, 2009
By:  
/s/ Murry Englard
 
Murry Englard, Chief Executive Officer
  

New York Health Care (CE) (USOTC:BBAL)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more New York Health Care (CE) Charts.
New York Health Care (CE) (USOTC:BBAL)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more New York Health Care (CE) Charts.